Contract Manufacturing

iBio is a leader in plant-based biologics manufacturing. Its FastPharming® System combines vertical farming, automated hydroponics, and glycan engineering technologies to rapidly deliver high-quality monoclonal antibodies, vaccines, bioinks and other proteins. Because the cell line development phase is eliminated, FastPharming offers significant time savings compared to traditional expression platforms. For instance, iBio produces milligram quantities of protein in as little as 6 weeks, gram quantities in 3 months, and greater than 10g of cGMP material in only 8 months. Additionally, FastPharming processes are easily scalable, produce high quality product and facilitate superior glycosylation control.